News
Showcase your company news with guaranteed exposure both in print and online The Future of Bay Area Biotech: Searching For Answers The Small Business Leaders awards program honors the dedicated ...
A Delaware jury on Thursday said Regeneron should get more than $400 million in damages in its long-running antitrust case against Amgen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback